Nuriye Özdemir
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 15
- Pancreatic and Hepatic Oncology Research 11
- Cancer Immunotherapy and Biomarkers 10
- HER2/EGFR in Cancer Research 10
- Cancer Treatment and Pharmacology 10
- Inflammatory Biomarkers in Disease Prognosis 10
-
- Gastric Cancer Management and Outcomes 24
- Metastasis and carcinoma case studies 12
- Emergency Medical Services top 5%
- Gastroenterology top 10%
- Co-authors
- Nurullah ZenginOzan YazıcıBerna ÖksüzoğluSercan AksoyGökmen Umut ErdemMehmet Alı Nahıt ŞendurSelma MetintaşYakup Bozkaya
- Journals
- Journal of Clinical Oncology (9 papers)SHILAP Revista de lepidopterología (3 papers)Scientific Reports (1 paper)
- Partner nations
- TürkiyeIndiaUnited States
In The Last Decade
Nuriye Özdemir
143 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 119
- Oncology 501
- Pulmonary and Respiratory Medicine 370
- Emergency Medical Services 75
- Gastroenterology 56
- Cancer Research 107
Countries citing papers authored by Nuriye Özdemir
This map shows the geographic impact of Nuriye Özdemir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nuriye Özdemir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nuriye Özdemir more than expected).
Fields of papers citing papers by Nuriye Özdemir
This network shows the impact of papers produced by Nuriye Özdemir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nuriye Özdemir. The network helps show where Nuriye Özdemir may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nuriye Özdemir, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 10 | |
| 10 | 2021 | 1 | |
| 11 | Is the Charlson Comorbidity Index a Prognostic Indicator for Toxicity and Mortality in Elderly Patients with Locally Advanced Rectal Cancer? | 2019 | 4 |
| 12 | Meme Kanserinde Epidemiyolojik Veriler, Risk Faktörleri, Risk Azaltıcı Yaklaşımlar | 2018 | 1 |
| 13 | 2015 | 27 | |
| 14 | Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breast carcinoma patients. | 2014 | 3 |
| 15 | Flurbiprofen-induced unilateral eyelid angioedema. | 2014 | 0 |
| 16 | 2014 | 16 | |
| 17 | 2014 | 5 | |
| 18 | 2013 | 2 | |
| 19 | 2012 | 7 | |
| 20 | 2010 | 2 |
About Nuriye Özdemir
Nuriye Özdemir is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Gastroenterology, having authored 153 papers that have together received 1.2k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (24 papers), Colorectal Cancer Treatments and Studies (15 papers), Metastasis and carcinoma case studies (12 papers), Pancreatic and Hepatic Oncology Research (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), HER2/EGFR in Cancer Research (10 papers), Cancer Treatment and Pharmacology (10 papers) and Inflammatory Biomarkers in Disease Prognosis (10 papers). The work is most often cited by research in Oncology (501 citations), Pulmonary and Respiratory Medicine (370 citations) and Emergency Medical Services (75 citations). Nuriye Özdemir has collaborated with scholars based in Türkiye, India and United States. Frequent co-authors include Nurullah Zengin, Ozan Yazıcı, Berna Öksüzoğlu, Sercan Aksoy, Gökmen Umut Erdem, Mehmet Alı Nahıt Şendur, Selma Metintaş, Yakup Bozkaya, Nebi Serkan Demirci and Ahmet Özet. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.